Fluicondrial 60 M

2% hyaluronic acid for intra-articular administration. Professional medical device.

Available variants:

• 2 ml syringe with 40 mg of hyaluronic acid
• 3 ml syringe with 60 mg of hyaluronic acid
• 4 ml syringe with 80 mg of hyaluronic acid

FLUICONDRIAL M is a medical device intended for injection into joints as a supplement to synovial fluid. Thanks to its viscoelastic and lubricating properties, FLUICONDRIAL helps restore the rheological state of joints in degenerative or post-traumatic conditions.

Indications for use of FLUICONDRIAL M

FLUICONDRIAL M is used to reduce pain and limit joint mobility resulting from osteoarthritis or trauma. By improving the properties of synovial fluid, the product exerts a protective effect on the joint, which in turn improves its functionality and reduces pain symptoms. FLUICONDRIAL M acts only on the joint into which it is injected, without causing any systemic effects.

Possibilities of use:

• degenerative joint disease (osteoarthritis)
• pain and limited joint mobility resulting from injuries or joint overloads
• other, according to the assessment of the attending physician and the patient's condition

Effects of FLUICONDRIAL M therapy:

• slows down cartilage degradation
• stimulates the growth of chondrocytes and inhibits their apoptosis
• soothes inflammatory processes
• reduces joint pain
• has antioxidant and antiradical properties
• stimulates synoviocytes to produce endogenous hyaluronic acid
• It only affects the joint into which it is injected, without causing any systemic effects.

Physicochemical properties of FLUICONDRIAL M:

• osmolarity 250 - 350 mOsm / kg
• molecular mass of hyaluronic acid before stabilization - 2.5 billion Da
• pH 6.5 - 7.5

Package contents:

Ampoule syringe containing 2 ml, 3 ml or 4 ml of non-pyrogenic gel, sterilized using moist heat.

Watch the presentation about the FLUICONDRIAL M product:

https://www.youtube.com/embed/79HBzl2_sLw

Warnings and precautions when using FLUICONDRIAL M: FLUICONDRIAL M is suitable for intra-articular injection only and should only be administered by a physician who has undergone specialized training in intra-articular injection technique. Before use, check the syringe for integrity and expiration date. Do not use needles other than those listed. This product must not be injected into a joint that is infected or severely inflamed. In the event of infection at the injection site or inflammation of the skin near the injection site, infiltration should be avoided. After intra-articular injection, it is recommended to advise the patient to avoid physical exertion that places stress on the joint and to resume normal activity after a few days.

Since FLUICONDRIAL M has not been tested in pregnant or breastfeeding women, its use in such cases is not recommended.

FLUICONDRIAL M should not be used on patients under 18 years of age. FLUICONDRIAL M is a single-use product; quality and sterility are only guaranteed if the syringe is tightly sealed. Any remaining product should be discarded and not reused, even after resterilization. Do not use the product if the packaging is already open or damaged. After use, the syringe should be disposed of in an appropriate container in accordance with applicable regulations.

Side effects: After FLUICONDRIAL M injection, temporary side effects may occur, such as pain, stiffness, warmth, redness, or swelling. These secondary symptoms can be alleviated by applying ice to the treated joint. These symptoms usually subside after a short time. If symptoms persist, consult your doctor.

Any other adverse reactions associated with FLUICONDRIAL M injection must be reported to the physician. As with any periarticular procedure, septic arthritis may occasionally occur if general injection precautions are not followed or if the injection site is not aseptic.

Interactions: Interactions exist between sodium hyaluronate and quaternary ammonium compounds, such as benzalkonium chloride solutions. Therefore, contact of FLUICONDRIAL M with these substances should be avoided.

Storage: FLUICONDRIAL M should be stored at 2 - 25 C (36 - 77 F) in its original, dry packaging. Protect from light, heat and frost. Keep out of reach of children.

FOR MEDICAL USE ONLY

Producer:

The Wave Innovation Group srls
Via Barucchi, 47/A – 37139 Verona (Italy)

Distributor:

Activlab Pharma
REGIS
Walerego Sławka Street 3a
30-633 Krakow
www.activlabpharma.pl

Due to the specific nature of the product, we suggest shipping in controlled conditions (UPS COURIER - PLN 44), any other form of shipping is chosen at the buyer's risk.